| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Regulatory Perspective on Validation of Surrogate Endpoints
|
Lesko, Lawrence J.
|
|
|
41 |
5 |
p. 587-594
|
artikel
|
| 2 |
A Statistician’s Viewpoint of Responders in the Treatment of Neuropathic Pain
|
Chen, Ling
|
|
|
41 |
5 |
p. 685-689
|
artikel
|
| 3 |
Biomarker Editorial: The Many Lives of the Biomarker
|
Lester, David S.
|
|
|
41 |
5 |
p. 551-553
|
artikel
|
| 4 |
Development of an Established Name: Analyzing Stem Based United States Adopted Naming
|
Carpenter, Patrick M.
|
|
|
41 |
5 |
p. 661-672
|
artikel
|
| 5 |
How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings
|
Boudes, Pol F.
|
|
|
41 |
5 |
p. 673-684
|
artikel
|
| 6 |
Imaging Biomarker Applications in Oncology Drug Development
|
Miller, Janet C.
|
|
|
41 |
5 |
p. 561-572
|
artikel
|
| 7 |
Implementation of a Biomarker into Drug Development: Example of Identifying the Right Imaging “Tool” for an Oncology Study
|
Peterson, Barry T.
|
|
|
41 |
5 |
p. 555-560
|
artikel
|
| 8 |
Interrater Reliability for Multiple Raters in Clinical Trials of Ordinal Scale
|
Sawa, Jungo
|
|
|
41 |
5 |
p. 595-605
|
artikel
|
| 9 |
Molecular Biomarkers
|
Laterza, Omar F.
|
|
|
41 |
5 |
p. 573-585
|
artikel
|
| 10 |
Notes on Test Equality in Stratified Noncompliance Randomized Trials
|
Lui, Kung-Jong
|
|
|
41 |
5 |
p. 607-618
|
artikel
|
| 11 |
Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study
|
Zhang, Lu
|
|
|
41 |
5 |
p. 619-627
|
artikel
|
| 12 |
Some Comments on Improving Collaboration Skills of the Statistician on a Drug Development Team
|
Johnson, James R.
|
|
|
41 |
5 |
p. 629-632
|
artikel
|
| 13 |
The December Effect in FDA Drug Approvals: Assessing the Submissions Echo Hypothesis
|
Graham, James B.
|
|
|
41 |
5 |
p. 653-659
|
artikel
|
| 14 |
The Demographic, Practice, and Prescribing Characteristics of US Clinical Investigators
|
Glass, Harold E.
|
|
|
41 |
5 |
p. 645-651
|
artikel
|
| 15 |
Using Data Mining to Predict Safety Actions from FDA Adverse Event Reporting System Data
|
Hochberg, Alan M.
|
|
|
41 |
5 |
p. 633-643
|
artikel
|
Tijdschrift beschrijving